Prime Medicine PRME EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Prime Medicine’s reported figures.
Based on trailing twelve months.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's EBITDA margin?
- Prime Medicine (PRME) reported EBITDA margin of -4,340% in Q4 2025.
- How has Prime Medicine's EBITDA margin changed year-over-year?
- Prime Medicine's EBITDA margin increased by 34.1% year-over-year, from -6,581.9% to -4,340%.
- What is the long-term trend for Prime Medicine's EBITDA margin?
- Over 2 years (2020 to 2025), Prime Medicine's EBITDA margin has grown at a 1494.8% compound annual growth rate (CAGR), from -17.1% to -4,340%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.